Article date: September 2003
By: Anita Annas, Kjell Carlström, Gunnar Alván, Ayman AL‐Shurbaji, in Volume 56, Issue 3, pages 334-336
Aims The effect of the CYP3A4 inhibitors ketoconazole and diltiazem on the pharmacokinetics of oestrone was studied in six healthy postmenopausal women after treatment with a single oral dose of oestradiol.
Methods Plasma oestrone concentrations were measured following the administration of 1) oestradiol, 2) oestradiol and ketoconazole and 3) oestradiol and diltiazem.
Results Treatment with ketoconazole increased the AUC of oestrone (+ 4029 nmol l−1 h; 95% CI on the difference: 1588, 6471) and its Cmax (+ 306 nmol l−1; 95% CI on the difference: 117, 496). The AUC and Cmax of oestrone tended to increase on treatment with diltiazem although this did not reach the level of statistical significance.
Conclusions The small increase in the plasma concentrations of oestrone formed from 17β‐oestradiol during co‐administration with ketoconazole is unlikely to be clinically significant.
DOI: 10.1046/j.1365-2125.2003.01885.x
View this article